This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Mannheim Gmbh. Active years: 1978.
Company Filing History:
Years Active: 1978
Title: Michael Klarwein: Innovator in Control Serum Technology
Introduction
Michael Klarwein is a notable inventor based in Garmisch-Partenkirchen, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of control serums. His innovative work has led to the creation of a patent that addresses the stability of alkaline phosphatase in serum solutions.
Latest Patents
Klarwein holds a patent for a "Control serum containing alkaline phosphatase of constant activity." This invention ensures that the activity of alkaline phosphatase in aqueous solutions, especially in reconstituted serum, remains constant. The method involves adding Mn²⁺ or Cd²⁺ ions to the phosphatase-containing solution, maintaining an end concentration of 0.05 to 0.5 mMol/liter of Mn²⁺ or 0.05 to 0.1 mMol/liter of Cd²⁺. This advancement is crucial for the reliability of biochemical assays.
Career Highlights
Michael Klarwein is associated with Boehringer Mannheim GmbH, a company known for its contributions to the life sciences and diagnostics sectors. His work at the company has been instrumental in advancing serum technology, which is vital for various medical applications.
Collaborations
Klarwein has collaborated with notable colleagues such as Wolfgang Gruber and Peter Roeschlau. Their combined expertise has contributed to the successful development of innovative solutions in the field of biochemistry.
Conclusion
Michael Klarwein's contributions to the field of control serum technology exemplify the impact of innovation in biochemistry. His patent for maintaining alkaline phosphatase activity is a testament to his dedication to advancing scientific knowledge and applications.